Articles tagged: Internal Bleeding

Pradaxa is a prescription anticoagulant approved by the Food and Drug Administration (FDA) for use in the United States in 2010. Pradaxa is manufactured by German company Boehringer Ingelheim. Recently Pradaxa has come under fire because numerous Pradaxa patients have suffered from death or extended hospitalization due to gastrointestinal bleeding, hemorrhagic stroke, and trauma-induced unusual bleeding events caused by Pradaxa.

Pradaxa is prescribed to patients suffering from atrial fibrillation. Prior to the introduction of Pradaxa, the most common treatments for atrial fibrillation in the United States were warfarin therapy, aspirin, or no treatment at all. Boehringer Ingelheim saw an opportunity and void in the market which they sought to fill with Pradaxa.

Many patients who took warfarin for atrial fibrillation complained about the drug because it is considered ‘inconvenient’ in many ways. To name a few, there are extensive dietary restrictions coupled with warfarin use, warfarin patients are required to have frequent blood sampling, there are numerous dangerous interactions between warfarin and other drugs, and finally there is a very specific INR range which patients must stay in for it to be safe and effective.

A major advantage which warfarin has over Pradaxa is its potential reversal agents. In severe bleeding events among patients taking warfarin, there are multiple options for the patients to safely reverse internal bleeding. Patients may supplement their intake with Vitamin K, have plasma infusions, and other factor concentrates that are relatively easy for doctors to monitor with available tests.

Pradaxa, however, does not have any known reversal agent once internal bleeding begins. This is a major concern, and is the grounds for some of the strongest Pradaxa lawsuits. Until early in 2012, Boehringer Ingelheim did not warn patients that Pradaxa has no reversal agent. Once internal bleeding begins in patients taking Pradaxa, they are unable to simply take Vitamin K to stop internal bleeding like warfarin patients can.

After hundreds of people died from internal bleeding while taking Pradaxa, Boehringer Ingelheim was forced to supplement their warning information to explicitly state that Pradaxa has no reversal agent. According to the New England Journal of Medicine, the only reversal agent for Pradaxa internal bleeding is to perform emergency dialysis. What emergency dialysis effectively does is actually remove and purify the blood from Pradaxa. Basically, it manually removes the Pradaxa from a patient’s system.

This type of procedure however is unlikely in the event of a serious bleeding incident. Emergency room doctors would likely be unable to perform emergency dialysis for a patient while trying to address a Pradaxa internal bleeding trauma. So, for all intents and purposes, there is no Pradaxa reversal agent.

Pradaxa Reversal Agent Lawsuits

If you or a loved one have taken Pradaxa and has suffered from a traumatic bleeding event which has either led to an extended hospitalization or death, you may be entitled to financial compensation through a Pradaxa Lawsuit. Currently, Pradaxa Lawsuits around the country are being gathered on behalf of those wronged by the makers of Pradaxa. There is no known Pradaxa reversal agent, and the makers of Pradaxa failed to warn patients of that fact for more than a year after Pradaxa’s introduction. Please speak with an expert Pradaxa Lawyer at our firm today to discuss your options for a Pradaxa lawsuit.

Pradaxa was first approved by the United States Food and Drug Administration in the fall of 2010 for the treatment of atrial fibrillation from a cause other than a heart valve issue. As a blood-thinner, Pradaxa reduces the ability of blood to clot, thereby reducing the risk of stroke and other related issues, such as deep vein thrombosis and pulmonary embolism. Patients who suffer from AFib are about five times more likely to suffer from stroke. Warfarin, an older type of anticoagulant treatment, was the medication primarily used for similar treatments before Pradaxa was released. When Pradaxa was first approved by the FDA, many patients quickly switched from warfarin. It is important to note that there are several key differences between Pradaxa and Warfarin which will be outlined in detail below:

Pradaxa Vs Warfarin: A Closer Look

Pradaxa is a DTI (direct thrombin inhibitor) and acts directly on thrombin, the bloods central clotting agent. Because of this, there is currently no antidote to its effects. Pradaxa may take up to 24 hours for the effects to wear off, even in the event of a serious bleeding incident.
Warfarin is a vitamin K antagonist, which means that it interferes with the levels of Vitamin K in the body. Vitamin K produces proteins that encourage clotting. This means that in the event of a major bleeding incident, ingesting large amounts of Vitamin K could potentially offset the anti-clotting effects of the drug.

Pradaxa cannot be counteracted with a prothrombin complex concentrate. In fact, there is no way to rapidly reverse Pradaxa’s effects.
Warfarin effects can be rapidly reversed using a prothrombin complex concentrate, as well as through intravenous Vitamin K.

Pradaxa was approved by the FDA for the treatment of AFib not from heart valve problem in 2010, only 2 years ago.
Warfarin has been prescribed by doctors for the prevention of stroke since 1954, almost 50 years. Throughout this time period it has also been studied extensively.

Pradaxa does not require regular blood monitoring and testing.
Patients taking Warfarin require regular blood monitoring in order to measure the International Normalized Ratio, which determines how long it would take your blood to form a clot.

Pradaxa is currently the subject of an FDA investigation regarding a large number of bleeding incidents that resulted in death.
Warfarin is not currently under FDA safety investigation.

File a Pradaxa Lawsuit: Speak with an Attorney

If you have suffered from bleeding or other serious side effects resulting from treatment with Pradaxa, you may want to consider pursuing a lawsuit. Call the Willis Firm today and we will provide you with a completely free and personalized consultation in order to discuss your legal options regarding this potentially harmful drug. You may be eligible for sizeable compensation for all of the suffering you have incurred as a result of your Pradaxa injuries. Don’t delay; contact us today.

Contact a Drug Lawsuit Lawyer & Attorney

For a free and confidential consultation, fill out our online case evaluation form or call us toll free at: 1-800-883-9858.

Contact an Attorney

Legal help: Contact an Attorney

An elderly man in Utah recently suffered a massive brain hemorrhage (bleeding in the brain) after what seemed to be a routine fall. What made this situation unique was that the man was taking the prescription anti-clotting drug Pradaxa. The man eventually died as a result of the hemorrhage and many believe that Pradaxa is to blame. In comparison with older blood-thinner medications, like warfarin, Pradaxa is a direct thrombin inhibitor which works directly on the bloods ability to clot. As a result, there is no way to reverse its effects when serious bleeding, like a cerebral hemorrhage occurs. In the case of the Utah man, all efforts to stop the bleeding in the brain were ineffective. Doctors tried both intravenous fluids as well as recombinant factor VIIa (a protein treatment).

Pradaxa and Bleeding in the Brain

Pradaxa is currently prescribed in the United States to reduce the risk of stroke in patients with Atrial Fibrillation from causes other than a heart valve problem. All anti-clotting drugs carry an increased risk of bleeding, which means that even minor trauma can result in a serious bleeding incident like bleeding in the brain. Other common terms for bleeding in the brain include: cerebral hemorrhaging, intracranial hemorrhaging, and intra cerebral hemorrhaging. Other factors that increase the risks of bleeding in the brain include elevated blood pressure, aneurysm, and liver diseases.

Pradaxa Bleeding in the Brain Symptoms

The following symptoms suggest that Pradaxa bleeding in the brain is taking place: nausea, severe headaches that come on suddenly, vision changes, difficulty with speech, loss of balance/coordination, and loss of consciousness. Any symptoms of a brain hemorrhage are particularly urgent in patients who are taking Pradaxa. This is because Pradaxa increases all risks associated with bleeding, and when a patient is taking Pradaxa treating the bleeding is much more difficult. Although there are ways to rapidly reverse the effects of other anti-clotting drugs, this is not the case for Pradaxa.

Experienced Pradaxa Bleeding in the Brain? File a Lawsuit

Although some patients who suffer from bleeding in the brain fully recover, others may experience loss of brain function, stroke, and even death. If you or a loved one experienced cerebral hemorrhaging while taking Pradaxa, you may be entitled to substantial monetary compensation. Call the Willis Law Firm in order to discuss your potential claim and have it evaluated free of charge or further obligation. Although primarily based in Houston, our firm is currently reviewing Pradaxa cases nationwide.

Patients who take the anti-clotting drugs Xarelto or Pradaxa may be at an increased risk of several types of serious internal bleeding. Although all anti-clotting drugs carry with them an increased risk of serious bleeding, Pradaxa carries with it additional risk due to the lack of a quick antidote to the anticoagulant effect that it has. Gastrointestinal bleeding, cerebral hemorrhaging (bleeding on the brain), as well as acute coronary syndrome (heart attacks due to blood clots) have all been reported by patients taking Xarelto and Pradaxa. In fact, around 300 Pradaxa related deaths have been reported in the time since the medication was FDA approved. Knowing about other compounding risk factors as well as being informed of the early signs of internal bleeding can help to potentially reduce associated Pradaxa risks.

Types of Patients with Increased Risks of Pradaxa Internal Bleeding

The following groups of people may be at an increased risk of serious bleeding, and should seriously consult with their doctor before taking a direct thrombin inhibitor or “blood thinner” like Pradaxa or Xarelto:

  • Patients who are already taking another prescription anti-clotting drug like warfarin
  • Patients with ongoing use of aspirin or other anti-inflammatory drugs (ibuprofen or naproxen)
  • Patients who are 75 and older
  • Patients with a prior history of bleeding problems
  • Patients with kidney disease
  • Patients with ulcers
  • Patients who are pregnant or plan to become pregnant
  • Patients who are planning to undergo any type of surgery, including dental surgery
  • Patients who are allergic to dabigatran, or any of the ingredients in the Pradaxa capsules

Signs and Symptoms of Internal Bleeding

Anti-clotting medications can result in a variety of side effects, some of which are very serious and even life threatening. Being aware of these side effects and symptoms can help to reduce the risks of internal bleeding while taking these medications. Some of the less severe side effects are stomach pain, nausea, and heartburn; however, if any of these persist or worsen over time, a doctor should be notified. The following symptoms are associated with internal bleeding, and a doctor should be notified immediately if any of the following manifest: discolored urine or stools, bleeding that occurs and lasts longer than usual (especially gum bleeding, menstrual bleeding, and nosebleeds), headache/dizziness, and swelling/joint pain.

File a Pradaxa or Xarelto Internal Bleeding Lawsuit: Speak to a Lawyer

Although primarily located in Houston, the Willis Law Firm is currently reviewing Pradaxa Internal Bleeding cases nationwide. If you or a loved one has experienced internal bleeding or other medical complications while taking Pradaxa or Xarelto, you may be eligible for financial compensation through filing a lawsuit. Contact our firm today for your initial case review free of charge or obligation. Pradaxa and Xarelto internal bleeding clients will not be required to pay any legal or attorney fees unless a recovery is obtained. Let us help you protect the interests of you and your family.

Xarelto Lawsuit for Internal Bleeding

Xarelto a similar blood thinner as Pradaxa has been linked to 100′s of potential serious side effects including Gastrointestinal bleeding, cerebral hemorrhaging (bleeding on the brain), intracranial bleeding, kidney bleeding and other serious and life threatening side effects.  Xeralto a product of Johnson and Johnson developed with Bayer AG, was approved by the FDA to treat the side effects of  atrial fibrillation and prevent clotting and strokes.

Xarelto however has been on the radar of many Doctors that are concerned that Xarelto and Pradaxa have too many incidences of internal bleeding and possibly have not been tested long enough before FDA approval and sale to a frail and fragile group of patients.

If you or a loved one has experienced internal bleeding or other medical complications while taking Xarelto, you may be eligible for financial compensation through filing a lawsuit. Contact our firm today for your initial case review free of charge or obligation.

Call Toll Free 1-800-883-9858 or fill out our form for a Free Xarelto Internal Bleeding Case Review

Since 2010, Pradaxa has been available in the United States as a treatment for patients who suffer from atrial fibrillation (AFib). Pradaxa quickly became popular in comparison with older blood-thinners, like warfarin, because it was easier to use and did not require the amount and frequency of blood tests of older medicine. Unfortunately, Pradaxa also has another major difference when compared against Coumadin (generic name: warfarin). In the event of internal bleeding, there is no quick cure or treatment for patients who are taking Pradaxa. In contrast, Vitamin K acts as a cure or treatment for patients who experience internal bleeding while taking warfarin. This discrepancy between drugs has recently become the subject of controversy; many patients have responded by filing Pradaxa internal bleeding lawsuits.

Pradaxa Internal Bleeding Study

A study recently published by the Journal of the American College of Cardiology evaluated the associated risks of bleeding in patients being treated with Pradaxa in comparison to those who received other forms of treatment. The findings of this study indicated that patients who were being treated with Pradaxa (generic name: dabigatran) had a statistically significantly higher risk of bleeding events and/or thromboembolic complications when compared with patients being treated with the older drug, warfarin. The results of this study, which was conducted using 290 patients, have prompted further investigation. It is believed that further clinical research will corroborate the data evaluated in this JACC research study.

Pradaxa Internal Bleeding FDA Investigation

After numerous post-market reports regarding internal bleeding while taking Pradaxa, the United States Food and Drug Administration has opened an official investigation regarding the matter. In December of 2011, the FDA issued an official drug safety communication on the topic of the serious bleeding reports among Pradaxa patients. Although all anticoagulant medications carry with them a heightened risk of internal bleeding and associated injuries, Pradaxa is a direct thrombin inhibitor and could potentially carry higher risks because there is not a specific cure to halt the internal bleeding once it begins.

File a Pradaxa Internal Bleeding Lawsuit: Speak to an Attorney

If you were prescribed the anticoagulant Pradaxa and have suffered from internal bleeding, you may want to consider the option of a Pradaxa internal bleeding lawsuit. Call the Willis Law Firm today, and our talented team of legal professionals will provide you with an initial case consultation free of charge and free of obligation. You may have a legal claim to substantial financial compensation in relation to the suffering you have experienced as a result of taking Pradaxa. All Pradaxa lawsuits are handled on a contingency fee basis, meaning that you are not held responsible for any legal or attorney’s fees unless a recovery is obtained in your favor.

Pradaxa and Xarelto are prescription blood-thinner medications called a direct thrombin inhibitor and they both are developed to prevent the formation of blood clots in the body. Approved for use in the US in 2010, Pradaxa was presented as a convenient alternative to older anticoagulants, like Coumadin/Warfarin, because it had similar rates of efficacy, but did not require the frequent blood testing and monitoring. Unfortunately, Pradaxa had another major difference when compared with the older drugs; there is no specific method for the reversal of bleeding that may occur during Pradaxa use. This quality of the drug has become the source of controversy in the wake of the discovery hundreds of Pradaxa related deaths. The FDA is currently conducting an evaluation of this information in an attempt to assess the safety of Pradaxa.

Types of Pradaxa & Xarelto Bleeding

Because it works as a blood-thinner and inhibits the formation of blood clots, Xarelto and Pradaxa have been linked to several different types of severe uncontrollable bleeding. Because there is no specific method for the reversal of Pradaxa and Xarelto bleeding, the results can be physically devastating and even potentially fatal. All of the serious types of bleeding have been experienced by patients prescribed Pradaxa:

Internal Bleeding: Internal bleeding is bleeding that occurs within the body and is not able to be seen. This type of Pradaxa bleeding can occur in many different places inside of the body including organs, tissues, and body cavities like the stomach, chest or even head. Because it cannot be seen outside of the body, internal bleeding may not be identified for many hours after it begins. Anti-clotting medicines like Pradaxa make internal bleeding especially dangerous and serious bleeding events may occur following what would otherwise be a minor injury. Because there is no specific method for the reversal of bleeding in patients who take Pradaxa, internal bleeding carries with it higher risks of complications including shock, organ failure, and even death.

Cerebral Hemorrhaging: A cerebral hemorrhage (also called a brain hemorrhage, intracerebral hemorrhage, intracranial hemorrhage) is a type of bleeding that occurs when an artery in the brain explodes and excessive bleeding occurs in the surrounding areas. The bleeding can take place in the actual brain matter or in the membranes and tissues that surround the brain. As the blood collects it increases pressure on the brain which decreases the flow of blood and kills necessary brain cells. When a cerebral hemorrhage takes places in someone that uses Pradaxa, it can be harder to treat because there is no specific method for the reversal of the bleeding effects of the medication. Complications include stroke, permanent loss of brain function, and even death.

Gastrointestinal Bleeding: Gastrointestinal bleeding is another type of serious bleeding that can be made worse due to an absence of method for the reversal of Pradaxa’s bleeding qualities. Usually gastrointestinal bleeding, also called GI bleeding, is a symptom of another condition rather than a medical condition in and of itself. Bleeding can occur at many different locations in both the upper and lower digestive tract. The upper digestive tract is comprised of the esophagus, stomach, and top of the small intestine, while the lower digestive tract is made of the bottom of the small intestine, as well as the colon, rectum, and anus. Most of the time GI bleeding is related to conditions like ulcers and hemorrhoids, but it can also be linked to life threatening causes of bleeding.

File a Pradaxa or Xarelto Lawsuit: Speak to an Attorney

If you or someone that you know has suffered from internal bleeding or another injury while taking the medication Xarelto or  Pradaxa, call the Willis Law Firm today for a free Pradaxa lawsuit review. You may be entitled to significant financial compensation, and when you call we will be able to assess your potential claim. All Pradaxa and  Xarelto internal bleeding cases are taken on a contingency fee basis, and presently our firm is reviewing these cases on a national level.

Pradaxa FDA Alert

In December of 2011, the United States Food and Drug Administration (FDA) released a Safety Announcement regarding recent studies conducted about Pradaxa causing internal bleeding. The Food and Drug Administration (FDA) stated that they were evaluating post-marketing (after sale) reports of severe bleeding events reported in Pradaxa patients. Pradaxa is a popular anticoagulant on the market with billions in sales.

In Pradaxa’s first year on the market, there were more than 250 deaths reportedly caused by Pradaxa related to internal bleeding. Results like that are bound to catch the eye of the Food and Drug Administration (FDA) and sure enough, they are currently reviewing the effects of Pradaxa. The Pradaxa FDA Alert states that Pradaxa is a blood thinning drug meant to lower the risk of stroke in certain patients.

At this time there is currently no Pradaxa FDA recall in effect. The FDA alert states that the bleeding caused by Pradaxa may lead to very severe and even fatal complications in patients. The Food and Drug Administration (FDA) is currently seeking to determine if the Pradaxa internal bleeding reports are occurring at higher rates than normal.

Pradaxa has been submitted into the Food and Drug Administration’s (FDA) Adverse Events Reporting System (AERS) to further investigate what adverse effects may be caused by Pradaxa and to determine if these Pradaxa internal bleeding deaths are occurring at a higher rate than expected.

Pradaxa and Xarelto are both fairly new blood thinning drugs on the market. Previous to their introduction, the most common anticoagulant treatment was warfarin. Pradaxa is preferred by many because it is believed to be easier to dose for patients, requiring fewer blood tests and less examination. However, if Pradaxa or Xarelto are causing significantly more internal bleeding deaths, then it may not be worth the risk according to many health experts.

One reason that warfarin is believed to be safer than Xarelto or Pradaxa is that in the event of warfarin internal bleeding; patients may supplement their intake with Vitamin K to offset much of the internal bleeding danger. For patients taking Pradaxa however, Vitamin K does not have the same negating effects on the internal bleeding.

The manufacturer of Pradaxa, German pharmaceutical company Boehringer Ingelheim, has admitted that roughly 260 cases of fatal internal bleeding have been linked to their drug Pradaxa. They claim that the number of Pradaxa deaths is below the average rate, but the trials are not conclusive. It is impossible to know if the 260 reported Pradaxa deaths are the only Pradaxa deaths which have occurred.

Pradaxa / Xarelto Lawsuit – Speak To a Lawyer

If you or a loved one took Pradaxa or Xarelto and have suffered from internal bleeding or know of someone who has suffered or died from internal bleeding which you believe may be caused by Xarelto or Pradaxa, you may be entitled to financial compensation. Potential Pradaxa and Xarelto internal bleeding lawsuits are currently being reviewed. Please contact our law firm immediately to see if you have a internal bleeding case caused by Xarelto or Pradaxa.

Pradaxa Lawsuit Cerebral HemorrhagePrescription drug Pradaxa has come under great scrutiny lately for its previously unforeseen negative effects among patients. During its premiere year on the market, Pradaxa was responsible for more than 260 deaths due to internal bleeding and a potential Pradaxa cerebral hemorrhage.

After only being on the market for 3 months, the United States Food and Drug Administration (FDA) had already received more than 300 reports from patients complaining about internal bleeding, cerebral hemorrhage, and other Pradaxa complications.

What is a Cerebral Hemorrhage?

A cerebral hemorrhage, such as a brain hemorrhage caused by Pradaxa, is a form of stroke. Brain hemorrhages are caused by the bursting of an artery in the brain causing bleeding in the localized area and surrounding tissues. This bleeding inside the brain (hemorrhaging) kills brain cells. The word hemorrhage comes from the Greek word for blood “hemo.” The word hemorrhage literally means ‘blood bursting forth.’

Other names for a cerebral hemorrhage include intracranial hemorrhage, intracerebral hemorrhage, and a brain hemorrhage. Cerebral hemorrhages account for approximately 13% of strokes.

What Happens During a Cerebral Hemorrhage?

Once the blood from the trauma area begins to irritate cerebral tissues, the result is swelling within the brain. This is also known as cerebral edema. The pooled blood from the cerebral hemorrhage collects into a body known as a hematoma. The increasing blood from the hemorrhage increases pressure on surrounding brain tissue and reduces the proper blood flow within the brain.

Cerebral hemorrhaging from such a trauma may happen inside the brain, between layers of the covering of the brain, or between the membranes that cover it and the brain. There are some very serious risk factors associated with a cerebral hemorrhage.

Cerebral Hemorrhage: Symptoms

Symptoms of a cerebral hemorrhage may vary from case to case. The cerebral hemorrhage symptoms depend on where the hemorrhaging is occurring, the seriousness of the bleeding, and the extent to which the surrounding tissue is affected. The onset of cerebral hemorrhage symptoms may also vary. In some cases, the cerebral hemorrhage symptoms may gradually develop and in others they may suddenly appear.

If you experience symptoms of cerebral hemorrhage, you should contact a medical professional. Some common symptoms of a Cerebral Hemorrhage may include:

  • Sudden and severe headache
  • Weakness in an arm or leg
  • Nausea and vomiting
  • Seizures with no history of seizures
  • Changes in vision
  • Loss of motor skills
  • Loss of balance

Pradaxa Cerebral Hemorrhage Lawsuit – Contact an Attorney

If you or a loved one have experienced a cerebral hemorrhage that you believe has been caused by prescription Pradaxa, you may have the right to compensation from the makers of the drug. If you or a loved one have suffered from a cerebral hemorrhage please contact our Pradaxa lawyers to review your Pradaxa Cerebral Hemorrhage Lawsuit.

Pradaxa is a prescription blood thinner manufactured by German pharmaceutical giant Boehringer Ingelheim. Prescription blood thinners or anticoagulants like Pradaxa are meant to prevent stroke and other problems arising from blockage. Pradaxa is a relatively new drug on the market, and in its first year of operation it has reportedly led to more than 260 Pradaxa deaths.

Recent reports suggest that the number of Pradaxa deaths from internal bleeding may actually be much higher than previously believed. The product liability lawyers at The Willis Law firm are currently reviewing potential Pradaxa Lawsuits for individuals who have suffered from severe internal bleeding caused by Pradaxa.

After reviewing the cases of the more than 260 Pradaxa patients who died from internal bleeding in Pradaxa’s first year, experts have suggested that the makers of Pradaxa, Boehringer Ingelheim, failed to adequately warn patients about the Pradaxa’s internal bleeding risk.

During the first three months that Pradaxa was on the market, the Food and Drug Administration (FDA) received more than 300 reports about Pradaxa problems related to internal bleeding and other Pradaxa complications. Most of these Pradaxa internal bleeding issues and other Pradaxa complications occurred among elderly patients.

According to another report filed by the Institute for Safe Medication Practices (ISMP), Pradaxa had more problems reported about it than 98.7% of other drugs that the ISMP was monitoring. A majority of these negative reports about Pradaxa related to internal bleeding among Pradaxa patients. Internal bleeding can be mild such as in cases of mild bruising, but it can also be very serious and potentially lead to death.

It is expected that some internal bleeding might occur from a blood thinner like Pradaxa because that is part of the functionality of the drug, but not to the extent that it has from Pradaxa. Pradaxa has led to hundreds of internal bleeding deaths that were not adequately warned about by the pharmaceutical company. It is for that reason that there are currently Pradaxa lawsuits being filed for patients who have suffered or died from Pradaxa related internal bleeding.

One reason that internal bleeding is especially bad in patients taking Pradaxa as opposed to alternative blood thinners is that it is difficult to counteract the blood thinning once it has begun in Pradaxa patients. Before Pradaxa, the most common blood thinning treatment was warfarin. Pradaxa was chosen by many over warfarin because it required less monitoring. However, if a patient taking warfarin begins to suffer from abnormal internal bleeding, they may counteract the internal bleeding side effects with Vitamin K. When a patient taking Pradaxa begins to suffer from abnormal internal bleeding, there is currently no known solution which acts like Vitamin K does for warfarin patients.

This is one major reason why Pradaxa may be much more dangerous than previously thought, and why there have been so many cases of internal bleeding among Pradaxa patients, even many leading to Pradaxa deaths.

Pradaxa Internal Bleeding Lawsuit – Speak to a Lawyer

If you have suffered from internal bleeding or know of someone who has suffered or died from internal bleeding which you believe may be caused by Pradaxa, you may be entitled to financial compensation from the makers of Pradaxa. Potential Pradaxa internal bleeding lawsuits are currently being reviewed. Please contact our law firm immediately to see if you have a Pradaxa internal bleeding case.